美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PALATIN TECHS INC

8.53

0.0000

成交量：- -

成交額：- -

市值：830.22萬

市盈率：- -

高：8.53

開：8.53

低：8.53

收：8.53

52周最高：19.51

52周最低：1.75

股本：97.33萬

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(LYR):-2.0233

淨資產收益率：-378.67%

總資產收益率：-70.26%

市淨率：0.72

市盈率(LYR):-4.22

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

帕拉丁宣佈口服MC4R激動劑PL7737在肥胖動物模型中取得積極臨床前療效數據

华尔街洞察

Palatin公布口服MC4R激動劑PL7737在肥胖動物模型中積極臨床前功效數據

华尔街洞察

Palatin口服肥胖新藥PL7737臨床前數據亮眼，計劃2026年啓動I期試驗

华尔街洞察

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PTNT"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTNT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTNT\",,,,,undefined,":{"symbol":"PTNT","market":"US","secType":"STK","nameCN":"PALATIN TECHS INC","latestPrice":8.53,"timestamp":1776788460000,"preClose":8.53,"halted":8,"volume":0,"delay":15,"changeRate":0,"floatShares":0,"shares":973300,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"04-21 12:21:00 EDT 延時","open":8.53,"high":8.53,"low":8.53,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1776801600000},"marketStatusCode":2,"adr":0,"exchange":"OTCQB","adjPreClose":8.53,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTNT\",,,,,undefined,":{"symbol":"PTNT","floatShares":0,"roa":"-70.26%","roe":"-378.67%","lyrEps":-2.023264,"shares":973300,"dividePrice":0,"high":8.53,"amplitude":0,"preClose":8.53,"low":8.53,"week52Low":1.75,"pbRate":"0.72","psRate":"0.93","week52High":19.505,"institutionHeld":0.1111,"latestPrice":8.53,"eps":0,"divideRate":0,"volume":0,"delay":15,"open":8.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTNT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"PTNT","oldSymbol":"PTNT","defaultRemindTime":1762957800000,"newSymbol":"PTN","exchange":"OTCQB","type":"symbolChange","dateTimestamp":1762923600000},{"market":"US","date":"2025-08-12","symbol":"PTNT","defaultRemindTime":1755005400000,"type":"split","dateTimestamp":1754971200000,"forFactor":50,"toFactor":1,"ratio":50}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTNT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTNT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTNT\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1115580369","title":"帕拉丁宣佈口服MC4R激動劑PL7737在肥胖動物模型中取得積極臨床前療效數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1115580369","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115580369?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 20:43","pubTimestamp":1752583435,"startTime":"0","endTime":"0","summary":"帕拉丁科技公司公布了其口服MC4R激动剂PL7737在肥胖动物模型中的积极临床前疗效数据。研究显示，PL7737与替西帕肽联用产生附加减肥效果，口服给药后在短短四天内即实现快速体重减轻。公司计划于2025年第四季度提交PL7737的新药研究申请（IND），为后续开发铺路。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159628542","title":"Palatin公布口服MC4R激動劑PL7737在肥胖動物模型中積極臨床前功效數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1159628542","media":"华尔街洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159628542?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 20:43","pubTimestamp":1752583426,"startTime":"0","endTime":"0","summary":"Palatin Technologies, Inc.今日宣布，其口服MC4R激动剂PL7737在肥胖动物模型中的临床前研究显示积极功效。研究结果表明，PL7737与tirzepatide联用可产生显著的加性减肥效果。效果惊人！口服PL7737在短短4天内即实现快速体重减轻。公司计划于2025年第四季度提交PL7737的新药临床试验申请（IND）。这一进展突显了该药物在肥胖治疗领域的潜力，为未来临床试验奠定基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105523922","title":"Palatin口服肥胖新藥PL7737臨床前數據亮眼，計劃2026年啓動I期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1105523922","media":"华尔街洞察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105523922?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 19:33","pubTimestamp":1752579200,"startTime":"0","endTime":"0","summary":"生物医药企业Palatin Technologies近日公布其口服MC4R激动剂PL7737在肥胖症动物模型中取得突破性临床前数据。更值得注意的是，当PL7737与替西帕肽联用时，两者产生协同减重效应，减重幅度超越单一用药效果。根据研发规划，Palatin将于2025年第四季度向美国食品药品监督管理局提交PL7737的新药临床试验申请，预计2026年上半年公布首个人体试验数据。值得关注的是，PL7737已获得美国FDA授予的孤儿药资格认定，适应症为瘦素受体缺乏症相关肥胖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTNT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PTNT\",params:#limit:6,delay:false,,,undefined,":[]}}